tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BridgeBio Oncology’s Promising Preclinical Data and Strategic Advancements Justify Buy Rating
PremiumRatingsBridgeBio Oncology’s Promising Preclinical Data and Strategic Advancements Justify Buy Rating
2M ago
BridgeBio Oncology announces new preclinical data on BBO-11818 study
Premium
The Fly
BridgeBio Oncology announces new preclinical data on BBO-11818 study
2M ago
BridgeBio Oncology management to meet with Oppenheimer
Premium
The Fly
BridgeBio Oncology management to meet with Oppenheimer
3M ago
BridgeBio Oncology initiated with an Overweight at Piper Sandler
PremiumThe FlyBridgeBio Oncology initiated with an Overweight at Piper Sandler
5M ago
BridgeBio Oncology initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
BridgeBio Oncology initiated with an Overweight at Cantor Fitzgerald
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100